A Comparative Study of the Respiratory Neonatal Outcomes Utilizing Dexamethasone Sodium Phosphate Versus a Mixture of Betamethasone Dipropionate and Betamethasone Sodium Phosphate As an Antenatal Corticosteroid Therapy

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2021 Dec 24

PMID 34949936

Citations 1

Authors

Omar F Altal

Ahmed H Al Sharie

Yazan O Al Zubi

Saif Aldin Rawabdeh

Wasim Khasawneh

Tamara Dawaymeh

Haneen Tashtoush

Rawan Obeidat

Omar M Halalsheh

Affiliations

Soon will be listed here.

Abstract

Objective: The aim of this study is to compare the respiratory neonatal outcomes utilizing antenatal dexamethasone sodium phosphate (DSP) versus a mixture of betamethasone dipropionate and betamethasone sodium phosphate (B-DP/SP) for preterm births.

Patients And Methods: All neonatal intensive care unit (NICU) admissions for prematurity were retrospectively identified at our center in the period between September 2016 and September 2018. Pregnant women expected to give preterm birth and received steroid injections whether it is DSP or B-DP/SP were included in the study. Maternal and obstetrical data along with the corresponding respiratory neonatal outcomes were extracted and analyzed. The population was categorized according to the gestational age into extremely preterm (less than 28 weeks), very preterm (28 up to 32 weeks) and moderate or late preterm (32 up to 37 weeks) in which the repository outcomes were compared in each sub-group.

Results: A total of 650 premature neonates were included in the analysis. B-DP/SP illustrated a significant reduction in the occurrence of respiratory distress syndrome (RDS) among moderate or late preterm neonates ( = 0.003) compared to DSP. In contrast, a non-significant difference was observed between B-DP/SP and DSP regarding apnea of prematurity and transient tachypnea of the newborn. The number of neonates developed chronic lung disease has been remarkably reduced when using DSP in extremely ( = 0.038) and very ( = 0.046) preterm neonates when compared to B-DP/SP.

Conclusion: The dual acting B-DP/SP formulation could possess a significant potential in reducing RDS in moderate or late preterm neonates, while DSP groups exhibit a favorable result in the development of chronic lung disease in extreme and very preterm cohorts. Such findings emphasize the need of further clinical trials, pharmacokinetics, pharmacodynamics and cost effectiveness studies to evaluate the durability of these findings.

Citing Articles

Molecular Characterization of Carbapenem-Resistant Isolated from Intensive Care Unit Patients in Jordanian Hospitals.

Al-Sheboul S, Al-Moghrabi S, Shboul Y, Atawneh F, Sharie A, Nimri L Antibiotics (Basel). 2022; 11(7).

PMID: 35884089 PMC: 9311868. DOI: 10.3390/antibiotics11070835.

References

. WHO: recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for cause of perinatal deaths. Modifications recommended by FIGO as amended October 14, 1976. Acta Obstet Gynecol Scand. 1977; 56(3):247-53. View

Altal O, Aleshawi A, Khrais M, Alkilany B, Abudalo T, Al Sharie A . The practice of intracytoplasmic sperm injection in Jordan: A clinical outcome study. Ann Med Surg (Lond). 2020; 57:196-200. PMC: 7406976. DOI: 10.1016/j.amsu.2020.07.042. View

Chawanpaiboon S, Vogel J, Moller A, Lumbiganon P, Petzold M, Hogan D . Global, regional, and national estimates of levels of preterm birth in 2014: a systematic review and modelling analysis. Lancet Glob Health. 2018; 7(1):e37-e46. PMC: 6293055. DOI: 10.1016/S2214-109X(18)30451-0. View

Tsakiridis I, Mamopoulos A, Athanasiadis A, Dagklis T . Antenatal Corticosteroids and Magnesium Sulfate for Improved Preterm Neonatal Outcomes: A Review of Guidelines. Obstet Gynecol Surv. 2020; 75(5):298-307. DOI: 10.1097/OGX.0000000000000778. View

Jobe A, Kemp M, Schmidt A, Takahashi T, Newnham J, Milad M . Antenatal corticosteroids: a reappraisal of the drug formulation and dose. Pediatr Res. 2020; 89(2):318-325. PMC: 7892336. DOI: 10.1038/s41390-020-01249-w. View

Lee S, Qi Z . Antenatal corticosteroids prior to preterm birth: betamethasone or dexamethasone?. Lancet Child Adolesc Health. 2019; 3(11):750-751. DOI: 10.1016/S2352-4642(19)30293-7. View

Thorp J, Jones P, Knox E, Clark R . Does antenatal corticosteroid therapy affect birth weight and head circumference?. Obstet Gynecol. 2002; 99(1):101-8. DOI: 10.1016/s0029-7844(01)01656-8. View

Murphy K, Willan A, Hannah M, Ohlsson A, Kelly E, Matthews S . Effect of antenatal corticosteroids on fetal growth and gestational age at birth. Obstet Gynecol. 2012; 119(5):917-23. DOI: 10.1097/AOG.0b013e31825189dc. View

Jobe A, Milad M, Peppard T, Jusko W . Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India. Clin Transl Sci. 2019; 13(2):391-399. PMC: 7070803. DOI: 10.1111/cts.12724. View

10.

Bloom S, Sheffield J, McIntire D, Leveno K . Antenatal dexamethasone and decreased birth weight. Obstet Gynecol. 2001; 97(4):485-90. DOI: 10.1016/s0029-7844(00)01206-0. View

11.

Torloni M, Betran A, Daher S, Widmer M, Dolan S, Menon R . Maternal BMI and preterm birth: a systematic review of the literature with meta-analysis. J Matern Fetal Neonatal Med. 2009; 22(11):957-70. DOI: 10.3109/14767050903042561. View

12.

Kopylov A, Novikov A, Kaysheva A, Vykhodets I, Karateev D, Zgoda V . Quantitative assessment of betamethasone dual-acting formulation in urine of patients with rheumatoid arthritis and ankylosing spondylitis after single-dose intramuscular administration and its application to long-term pharmacokinetic study. J Pharm Biomed Anal. 2017; 149:278-289. DOI: 10.1016/j.jpba.2017.11.021. View

13.

Kirshenbaum M, Mazaki-Tovi S, Amikam U, Mazkereth R, Sivan E, Schiff E . Does antenatal steroids treatment prior to elective cesarean section at 34-37 weeks of gestation reduce neonatal morbidity? Evidence from a case control study. Arch Gynecol Obstet. 2017; 297(1):101-107. DOI: 10.1007/s00404-017-4557-8. View

14.

Platt M . Outcomes in preterm infants. Public Health. 2014; 128(5):399-403. DOI: 10.1016/j.puhe.2014.03.010. View

15.

Porto A, Coutinho I, Correia J, Ramos Amorim M . Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ. 2011; 342:d1696. PMC: 3075234. DOI: 10.1136/bmj.d1696. View

16.

Lin P, Stoll B . Necrotising enterocolitis. Lancet. 2006; 368(9543):1271-83. DOI: 10.1016/S0140-6736(06)69525-1. View

17.

Salem I, Najib N . Pharmacokinetics of betamethasone after single-dose intramuscular administration of betamethasone phosphate and betamethasone acetate to healthy subjects. Clin Ther. 2011; 34(1):214-20. DOI: 10.1016/j.clinthera.2011.11.022. View

18.

Crowther C, Ashwood P, Andersen C, Middleton P, Tran T, Doyle L . Maternal intramuscular dexamethasone versus betamethasone before preterm birth (ASTEROID): a multicentre, double-blind, randomised controlled trial. Lancet Child Adolesc Health. 2019; 3(11):769-780. DOI: 10.1016/S2352-4642(19)30292-5. View

19.

Berard A, Le Tiec M, De Vera M . Study of the costs and morbidities of late-preterm birth. Arch Dis Child Fetal Neonatal Ed. 2012; 97(5):F329-34. DOI: 10.1136/fetalneonatal-2011-300969. View

20.

Gueguen N, Lourel M, Pascual A, Mouda F . [A simple method to determine and evaluate "effect size"]. Sante. 2011; 21(2):103-5. DOI: 10.1684/san.2011.0240. View